Subscribe To
Is most-watched stock enphase energy, inc. (enph) worth betting on now?
Recently, Zacks.com users have been paying close attention to Enphase Energy (ENPH). This makes it wort...
September 19, 2023, 10:31 am
Enphase's (enph) products see enhanced presence in australia
Enphase's (ENPH) installers witness the increased presence of the company's home energy system in Australia's solar market....
September 19, 2023, 9:01 am
Tocvan achieves milestone towards full ownership of pilar project as it outlines next phase of drilling
Tocvan Ventures Corp. (CSE:TOC) told investors it has submitted its exercise notice to Colibri Resources for a majority ownership stake of 51% in the...
September 19, 2023, 8:17 am
Chariot fully focused on executing core objectives, anchois gas project continues to progress
Chariot Ltd (AIM:CHAR, OTC:OIGLF)) told investors, in its interim results statement, that it is fully focused on executing its core objectives “to d...
September 19, 2023, 3:29 am
60 degrees pharma withdraws covid phase iib ind, will resubmit pending assessment of ability to meet fda requirements
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary of 60 Degrees Pharmaceuticals, has withdrawn it...
September 18, 2023, 8:16 pm
Bitcoin bull run predicted post-april 2024, says analyst planb
The prominent cryptocurrency Bitcoin (BTC) is expected to enter its next phase of bullish growth after ...
September 18, 2023, 6:59 pm
Cyteir: although the company is winding down, the lead asset had promise
Cyteir is a developer of cancer therapeutics that has decided to suspend operations and sell all assets. Their lead candidate, CYT-0851, is an MCT1 in...
September 18, 2023, 5:32 pm
Vigil neuroscience: interesting early data, wait for phase 2
Vigil Neuroscience is developing medicines for neurodegenerative diseases by restoring microglial function. Their lead candidate, VGL101, is a monoclo...
September 18, 2023, 2:38 pm
Bitcoin drops 20% from july highs as fear sets in. why is $qube bullish?
Read our article and explore why InQubeta ($QUBE) is performing so well in its presale phases amidst Bitcoin ($BTC) drops by 20% from July highs. Read...
September 18, 2023, 1:59 pm
Enph stock alert: enphase energy announces australian expansion
In a move signaling the future of clean energy, Enphase Energy (NASDAQ: ENPH ) has reported increased A...
September 18, 2023, 1:47 pm
Enphase energy ($enph) announces increased adoption of iq8 microinverter systems in australia
Enphase Energy (NASDAQ: ENPH), a global energy tech leader, has announced increased adoption of its En<...
September 18, 2023, 10:56 am
Eur/usd forecast: further consolidation likely in the near term
After posting losses for the eighth consecutive week, EUR/USD started the new week in a calm manner and went into a consolidation ...
September 18, 2023, 8:59 am
Eur/jpy technical: bulls may have reached a key bearish reversal zone
The 9-month rally seen in the EUR/JPY has reached a key major resistance zone of 158.55/159.80. Several technical elements have started to hint at sig...
September 18, 2023, 6:56 am
Eur/jpy technical: bulls may have reached a key bearish reversal zone
The 9-month rally seen in the EUR/JPY has reached a key major resistance zone of 158.55/159.80. Several technical elements have started to hint at sig...
September 18, 2023, 6:19 am
Scratching the surface: allakos' novel take on urticaria
Allakos displays fiscal discipline with YoY reductions in R&D and G&A, suggesting resource reallocation to pivotal assets like lirentelimab. Lirenteli...
September 18, 2023, 2:07 am
Down 55% on the year, is enphase a buy?
Enphase stock is up nearly 30x over five years, but down 55% for 2023. Has the U.S. residential solar m...
September 17, 2023, 6:15 am
How cheap is enphase stock really, and is there a better stock to buy right now?
It appears that Enphase's dip could be temporary as it expands its product line and enters new geographies. The stock may be cheap, but this investor ...
September 16, 2023, 5:09 am
Bitcoin’s bottom in?
Bitcoin bottomed the past week in our ideal target zone, and based on its four phases, it should be close to a new Bull run lasting until late 2025. T...
September 15, 2023, 8:20 pm
Actinium pharmaceuticals trickling down through 2023: are they flying under the radar?
Actinium is making radiolabeled antibodies for use in hematologic cancers. Previously reported phase 3 ...
September 15, 2023, 7:02 pm
Decibel therapeutics' cvr appears around fair value
Decibel Therapeutics is being acquired by Regeneron for a cash consideration of $4/share and a CVR linked to DB-OTO. DB-OTO is a gene therapy for hear...
September 15, 2023, 6:32 pm